ALKERMES | Stammkapital



Ordinary Share Capital Veränderung Datum
AbbVie USD 18M 0 2024-12
Acadia Pharmaceuticals USD 16K 0 2024-12
ALKERMES USD 1.8M 35K 2025-03
Amgen USD 33.58B 45M 2025-03
Biogen USD 100K 0 2024-12
BioMarin Pharmaceutical USD 192K 1000 2025-03
Bristol-Myers Squibb USD 292M 0 2025-03
Eli Lilly USD 592.6M 200K 2025-03
Gilead Sciences USD 1000K 0 2024-12
Ionis Pharmaceuticals USD 159K 1000 2025-03
J&J USD 3.12B 0 2024-12
Malin Corporation EUR 200K 0 2024-06
Merck USD 1.79B 0 2024-12
Neurocrine Biosciences USD 100K 0 2024-12
Otsuka Holdings JPY 81.69B 0 2025-03
Pfizer USD 480M 0 2024-12
Regeneron Pharmaceuticals USD 0 102K 2025-03
Vertex Pharmaceuticals USD 2.6M 0 2024-12



ALKERMES Stammkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.